Finnish medical tech firm Bioretec fast-tracks RemeOs™ Spinal Interbody Cage development with FDA's Breakthrough Device designation, predicting €65M sales by 2028.

Bioretec, a Finnish medical tech firm, is fast-tracking the development of its RemeOs™ Spinal Interbody Cage, which is designed to enhance spinal surgery outcomes. This device, made from an MRI-compatible, absorbable magnesium alloy, aims to improve patient recovery by addressing issues with traditional implants. Following FDA's Breakthrough Device designation, Bioretec has updated its financial targets, forecasting €65 million in sales by 2028.

October 04, 2024
4 Articles

Further Reading